PROFILE OF BARNEY GRAHAM, M.D., Ph.D.
Chief, Viral Pathogenesis Laboratory and Clinical Trials Core
Barney Graham has been appointed Director of Clinical Studies
and tenured investigator at the Dale and Betty Bumpers Vaccine
Research Center (VRC). Dr. Graham comes to the VRC from Vanderbilt
University School of Medicine, where he was professor of medicine
and associate professor of microbiology and immunology. For
the past 13 years, Dr. Graham also headed the AIDS Vaccine
Evaluation Unit at Vanderbilt, part of the national clinical
trials network funded by NIAID that tests candidate AIDS vaccines
Dr. Graham graduated magna cum laude from Rice
University in Houston, and completed his M.D. at the University
of Kansas School of Medicine, where he received the Roscoe
Falls Morton Award for "outstanding senior student in
internal medicine." He completed his internship and residency
in internal medicine at Vanderbilt, where he also finished
his Ph.D. before joining the university as a full-time faculty
member. In 1993, Vanderbilt honored him with the Grant Liddle
Research Appreciation Award for "promoting interest in
research among young physicians."
NIH recognized the potential and importance
of Dr. Graham's work early on, and has funded many of his
studies on candidate vaccines for respiratory syncytial virus
(RSV) and AIDS. In addition to his duties at Vanderbilt, Dr.
Graham consults for many public health organizations, such
as the World Health Organization, UNAIDS and the International
AIDS Vaccine Initiative. He was recently appointed to the
editorial board for the Journal of AIDS, and reviews manuscripts
for major virology, immunology and clinical research journals.
Dr. Graham has served on many NIAID committees and chaired
the executive committee for the AIDS Vaccine Evaluation Group.
He is a member of many professional scientific societies,
including the American Society of Clinical Investigation,
and is a Fellow in the American College of Physicians and
the American Academy of Microbiology.
Dr. Graham's extensive experience in molecular
virology and vaccine research, his pivotal role in establishing
NIAID's AIDS Vaccine Evaluation Group, and his community involvement
make him a unique selection for this position. As director
of clinical studies, Dr. Graham oversees the design of clinical
trials and selection of vaccine candidates, and will develop
the infrastructure for the clinical trials program at the
VRC. He also serves on the VRC Executive Committee, which
analyzes the priorities of the Center and evaluates potential
vaccine candidates. As a tenured investigator, Dr. Graham
continues his laboratory studies in the pathogenesis of RSV
and in the development of vaccines.
For more information on Dr.
program, please refer to his laboratory
description or bibliography.